Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Communications rethink for Health Canada

Government review of regulator’s outreach efforts follows recall of birth-control drug

- PMLiVE

Public unaware of main cause of liver cancer

Janssen-backed survey finds one in six people is aware of viral hepatitis role in the disease

- PMLiVE

Homecare must be part of UK health debate, says NCHA

New CEO promises “greater leadership and clearer advocacy”

- PMLiVE

Sanofi launches a monster mobile diabetes game

Monster Manor iPhone and Android apps aim to encourage better management of the condition

- PMLiVE

GSK and Genmab file Arzerra for first-line use in US

Plans progress to expand the chronic lymphocytic leukaemia drug

Actelion HQ Switzerland

Actelion gets US green light for new PAH drug Opsumit

Approval will help reduce impact of generic competition for Tracleer

- PMLiVE

This month in 1884: How ‘friable’ pills changed medicine delivery

This month in 1884: Dr William Upjohn files key structural patent for revolutionary pill design

- PMLiVE

Mylan hires Jacek Glinka as European head

He will join the firm from Poland’s Polpharma

- PMLiVE

Does your medical education drive change in clinical practice?

How to advance outcomes for patients using a medical education process, by Jan Steele PhD, operations director, Lucid

Lucid Group Communications Limited

- PMLiVE

Astellas wins NICE backing for Xtandi in prostate cancer

England’s health guidance body says drug can be used in advanced cases of the disease

- PMLiVE

Amarin slides as FDA panel votes against fish oil therapy

Advisory committee wants more data on Vascepa

- PMLiVE

Budget deal brings FDA back to life

US Congress agreement allows employees at the regulator to return to work

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links